How to Help Your Patients Find Naphazoline in Stock: A Provider's Guide

When a patient calls your office frustrated because they can't find their medication at the pharmacy, it creates an interruption to your workflow — and a potentially poor experience for your patient. For naphazoline specifically, the confusion stems from the discontinuation of standalone products and the transition to combination formulations. This guide gives you a practical playbook for talking patients through the situation and getting them the treatment they need.

Why Patients Are Confused About Naphazoline Availability

Standalone naphazoline hydrochloride ophthalmic solution was discontinued by its manufacturers. This was not a safety recall — the FDA confirmed no safety or efficacy issues drove the discontinuation. However, patients searching for "naphazoline" at the pharmacy often can't find it labeled that way anymore.

The drug remains available as an active ingredient in multiple OTC combination products, but patients may not recognize these products as containing naphazoline. Providers who can quickly orient patients to the right product names reduce unnecessary callbacks and prescription confusion.

What to Tell Patients: Script for Your Front Desk or Clinical Staff

When a patient calls about naphazoline availability, your staff can use language like:

"The plain naphazoline product was discontinued by the manufacturer, but it's still available under other brand names at the pharmacy. Ask your pharmacist for Clear Eyes Redness Relief or Naphcon-A — both contain naphazoline as the active ingredient and are available over the counter without a prescription."

Combination Products Containing Naphazoline — Quick Reference

For your patient education materials or office handouts, here is a quick reference list of naphazoline-containing OTC products:

Clear Eyes Redness Relief — naphazoline 0.012% + glycerin 0.2% — lubricant/redness reliever

Naphcon-A — naphazoline 0.027% + pheniramine 0.315% — allergy + redness

Visine-A / Opcon-A — naphazoline + pheniramine — allergy + redness

Clear Eyes ACR / VasoClear A — naphazoline + zinc sulfate — astringent/redness reliever

Rohto Cool Eye Drops — naphazoline in select formulations — redness reliever

When to Recommend an Alternative Instead

If the patient's history or clinical presentation makes naphazoline products less appropriate, consider directing them to alternatives. Key clinical scenarios:

Allergic conjunctivitis: Direct to ketotifen (Alaway) or olopatadine (Pataday) — these treat the underlying allergic mechanism

Rebound redness/chronic use: Switch to brimonidine (Lumify) or a lubricating drop; counsel on the 72-hour limit

Narrow-angle glaucoma: Avoid all ophthalmic vasoconstrictors; lubricating drops are safe

MAO inhibitor use: Contraindicated — risk of hypertensive crisis; use lubricating drops only

Children under 6: Not recommended for self-medication with naphazoline products; consult pediatric ophthalmologist

The Pharmacy Location Problem: Why Patients Still Struggle

Even though naphazoline products are widely available nationally, individual pharmacy locations may temporarily be out of a specific SKU. Some patients — especially those in rural areas, those without transportation, or those managing multiple prescriptions — may have difficulty checking multiple pharmacies. This problem isn't unique to naphazoline; it affects many medications.

How to Refer Patients to medfinder

medfinder is a service designed exactly for this problem. When you refer a patient to medfinder, they submit their medication name, dosage, and zip code. medfinder calls local pharmacies to check stock and texts the patient which locations have the medication available. This works for all medications — prescription and OTC — and reduces the back-and-forth between your practice and the patient.

Consider adding medfinder to your patient discharge instructions or after-visit summary for patients who may have difficulty filling medications. This is especially valuable for elderly patients, patients managing complex medication regimens, or those in areas with limited pharmacy access.

Summary for Providers

Standalone naphazoline was discontinued as a market decision — no safety recall

Naphazoline is still available OTC in combination products (Clear Eyes, Naphcon-A, Visine-A)

Counsel patients on 72-hour use limit; educate about rebound redness

For allergic conjunctivitis, prefer ketotifen or olopatadine over naphazoline

Refer patients to medfinder when they have difficulty finding medications at their pharmacy